Axsome Therapeutics (AXSM) FCF Margin (2022 - 2026)
Axsome Therapeutics (AXSM) reported FCF Margin of 10.89% for Q1 2026, up 2510.0% on a YoY basis from 0.42% in Q1 2025, and down 13.99% sequentially from 9.55% in Q4 2025.
Axsome Therapeutics (AXSM) FCF Margin (2022 - 2026) Analysis & Trends
Axsome Therapeutics (AXSM) has 5 years of FCF Margin data on file, last reported at 10.89% in Q1 2026.
- For the quarter ending Q1 2026, FCF Margin rose 2510.0% year-over-year to 10.89%; the trailing twelve-month figure through Mar 2026 stood at 10.02% (up 2783.0% YoY), and the FY2025 full-year result was 14.7%, up 1866.0% from the prior year.
- FCF Margin eased to 10.89% in Q1 2026, from 9.55% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 0.58% in Q3 2025 to a low of 5246.4% in Q4 2024.
- A 5-year average of 396.3% and a median of 39.22% in 2023 frame the typical range for FCF Margin.
- Across the five-year window, FCF Margin tumbled 520394 bps in 2024 and jumped 523685 bps in 2025, its largest moves.
- Tracing AXSM's FCF Margin over 5 years: stood at 113.84% in 2022, then jumped by 63 bps to 42.46% in 2023, then slumped by 12257 bps to 5246.4% in 2024, then soared by 100 bps to 9.55% in 2025, then dropped by 14 bps to 10.89% in 2026.
- Business Quant data shows AXSM's FCF Margin at 10.89% in Q1 2026, 9.55% in Q4 2025, and 0.58% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 10.45% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 43.35% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 23.53% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Axsome Therapeutics | 12.37 Bn | 12.06 Bn | 176.48 Mn | -10.89% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.89% |
| Dec 31, 2025 | -9.55% |
| Sep 30, 2025 | 0.58% |
| Jun 30, 2025 | -21.62% |
| Mar 31, 2025 | -35.99% |
| Dec 31, 2024 | -5,246.40% |
| Sep 30, 2024 | -17.87% |
| Jun 30, 2024 | -34.60% |
| Mar 31, 2024 | -71.42% |
| Dec 31, 2023 | -42.46% |
| Sep 30, 2023 | -93.30% |
| Jun 30, 2023 | -118.81% |
| Mar 31, 2023 | -6.23% |
| Dec 31, 2022 | -113.84% |
| Sep 30, 2022 | -135.49% |
| Jun 30, 2022 | -382.97% |